Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial

Peer Review reports

Original Submission
16 Sep 2020	Submitted	Original manuscript
11 Sep 2021	Reviewed	Reviewer Report - Wadsley Jonathan
19 Sep 2021	Reviewed	Reviewer Report
7 Oct 2021	Author responded	Author comments - Sebastian Krug
Resubmission - Version 2
7 Oct 2021	Submitted	Manuscript version 2
Publishing
21 Oct 2021	Editorially accepted
12 Nov 2021	Article published	10.1186/s12885-021-08900-7

Back to article page